1. Targeted Drug Repurposing Against the SARS-CoV-2 E channel Identifies Blockers With in vitro Antiviral Activity

    This article has 3 authors:
    1. Prabhat Pratap Singh Tomar
    2. Miriam Krugliak
    3. Isaiah Tuvia Arkin

    Reviewed by ScreenIT

    This article has 1 evaluationAppears in 1 listLatest version Latest activity
  2. Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice

    This article has 15 authors:
    1. David R. Martinez
    2. Alexandra Schäfer
    3. Sarah R. Leist
    4. Dapeng Li
    5. Kendra Gully
    6. Boyd Yount
    7. Joy Y. Feng
    8. Elaine Bunyan
    9. Danielle P. Porter
    10. Tomas Cihlar
    11. Stephanie A. Montgomery
    12. Barton F. Haynes
    13. Ralph S. Baric
    14. Michel C. Nussenzweig
    15. Timothy P. Sheahan

    Reviewed by ScreenIT

    This article has 1 evaluationAppears in 1 listLatest version Latest activity
  3. Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell

    This article has 31 authors:
    1. Maritza Puray-Chavez
    2. Kyle M. LaPak
    3. Travis P. Schrank
    4. Jennifer L. Elliott
    5. Dhaval P. Bhatt
    6. Megan J. Agajanian
    7. Ria Jasuja
    8. Dana Q. Lawson
    9. Keanu Davis
    10. Paul W. Rothlauf
    11. Zhuoming Liu
    12. Heejoon Jo
    13. Nakyung Lee
    14. Kasyap Tenneti
    15. Jenna E. Eschbach
    16. Christian Shema Mugisha
    17. Emily M. Cousins
    18. Erica W. Cloer
    19. Hung R. Vuong
    20. Laura A. VanBlargan
    21. Adam L. Bailey
    22. Pavlo Gilchuk
    23. James E. Crowe
    24. Michael S. Diamond
    25. D. Neil Hayes
    26. Sean P.J. Whelan
    27. Amjad Horani
    28. Steven L. Brody
    29. Dennis Goldfarb
    30. M. Ben Major
    31. Sebla B. Kutluay

    Reviewed by ScreenIT

    This article has 1 evaluationAppears in 1 listLatest version Latest activity
  4. SARS CoV-2 Nucleoprotein Enhances the Infectivity of Lentiviral Spike Particles

    This article has 6 authors:
    1. Tarun Mishra
    2. M. Sreepadmanabh
    3. Pavitra Ramdas
    4. Amit Kumar Sahu
    5. Atul Kumar
    6. Ajit Chande

    Reviewed by ScreenIT

    This article has 1 evaluationAppears in 1 listLatest version Latest activity
  5. Host-Virus Chimeric Events in SARS-CoV-2-Infected Cells Are Infrequent and Artifactual

    This article has 12 authors:
    1. Bingyu Yan
    2. Srishti Chakravorty
    3. Carmen Mirabelli
    4. Luopin Wang
    5. Jorge L. Trujillo-Ochoa
    6. Daniel Chauss
    7. Dhaneshwar Kumar
    8. Michail S. Lionakis
    9. Matthew R. Olson
    10. Christiane E. Wobus
    11. Behdad Afzali
    12. Majid Kazemian

    Reviewed by ScreenIT

    This article has 1 evaluationAppears in 1 listLatest version Latest activity
  6. Computational assessment of the spike protein antigenicity reveals diversity in B cell epitopes but stability in T cell epitopes across SARS-CoV-2 variants

    This article has 3 authors:
    1. Anni Ge
    2. Melissa Rioux
    3. Alyson A. Kelvin

    Reviewed by ScreenIT

    This article has 1 evaluationAppears in 1 listLatest version Latest activity
  7. Hamster and ferret experimental infection with intranasal low dose of a single strain of SARS-CoV-2

    This article has 14 authors:
    1. Elodie Monchatre-Leroy
    2. Sandrine Lesellier
    3. Marine Wasniewski
    4. Evelyne Picard-Meyer
    5. Céline Richomme
    6. Franck Boué
    7. Sandra Lacôte
    8. Séverine Murri
    9. Coralie Pulido
    10. Johann Vulin
    11. Francisco J. Salguero
    12. Meriadeg Ar Gouilh
    13. Alexandre Servat
    14. Philippe Marianneau

    Reviewed by ScreenIT

    This article has 2 evaluationsAppears in 1 listLatest version Latest activity
  8. In vitro inactivation of SARS-CoV-2 with 0.5% povidone iodine nasal spray (Nasodine) at clinically relevant concentrations and timeframes using tissue culture and PCR based assays

    This article has 6 authors:
    1. S.P. Tucker
    2. S. Goodall
    3. J. Julander
    4. M. Mendenhall
    5. P. Friedland
    6. P.L. Molloy

    Reviewed by ScreenIT

    This article has 1 evaluationAppears in 1 listLatest version Latest activity
  9. Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape

    This article has 46 authors:
    1. Tyler N. Starr
    2. Nadine Czudnochowski
    3. Fabrizia Zatta
    4. Young-Jun Park
    5. Zhuoming Liu
    6. Amin Addetia
    7. Dora Pinto
    8. Martina Beltramello
    9. Patrick Hernandez
    10. Allison J. Greaney
    11. Roberta Marzi
    12. William G. Glass
    13. Ivy Zhang
    14. Adam S. Dingens
    15. John E. Bowen
    16. Jason A. Wojcechowskyj
    17. Anna De Marco
    18. Laura E. Rosen
    19. Jiayi Zhou
    20. Martin Montiel-Ruiz
    21. Hannah Kaiser
    22. Heather Tucker
    23. Michael P. Housley
    24. Julia di Iulio
    25. Gloria Lombardo
    26. Maria Agostini
    27. Nicole Sprugasci
    28. Katja Culap
    29. Stefano Jaconi
    30. Marcel Meury
    31. Exequiel Dellota
    32. Elisabetta Cameroni
    33. Tristan I. Croll
    34. Jay C. Nix
    35. Colin Havenar-Daughton
    36. Amalio Telenti
    37. Florian A. Lempp
    38. Matteo S. Pizzuto
    39. John D. Chodera
    40. Christy M. Hebner
    41. Sean P.J. Whelan
    42. Herbert W. Virgin
    43. David Veesler
    44. Davide Corti
    45. Jesse D. Bloom
    46. Gyorgy Snell

    Reviewed by ScreenIT

    This article has 1 evaluationAppears in 1 listLatest version Latest activity
  10. The Inhaled Steroid Ciclesonide Blocks SARS-CoV-2 RNA Replication by Targeting the Viral Replication-Transcription Complex in Cultured Cells

    This article has 8 authors:
    1. Shutoku Matsuyama
    2. Miyuki Kawase
    3. Naganori Nao
    4. Kazuya Shirato
    5. Makoto Ujike
    6. Wataru Kamitani
    7. Masayuki Shimojima
    8. Shuetsu Fukushi

    Reviewed by ScreenIT

    This article has 1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 203 of 248 Next